100% Canadian Owned and Operated
The Seaford Story
Seaford Pharmaceuticals is a proud Canadian company founded in 1991 by the Seales family. Since then, we have been dedicated to developing and marketing specialty healthcare solutions to Canadians and abroad.
Working closely with strategic partners, our niche products span across a variety of therapeutic areas, including women’s health, iron deficiency, anemia, digestive health and skin care. Our Canadian portfolio includes market leading products in hospitals such as Seacalphyx and in OTC the #1 doctor recommended anti-perspirant DRYSOL.
We have a strong leadership team that has a wealth of knowledge in both the Canadian and global pharmaceutical industry. Combined with our sales force, we are able to leverage our relationships with pharmacists, specialists and family physicians to offer specialty healthcare solutions.
LEADERSHIP Team
Ron Seales
CEO, Founder
Tamara Seales
President
Paul Varady
Chief Scientific Officer
Andrew Seales
VP of International Business Development
Christopher McMahon
Director of Operations
Randy Beitz
Director of Finance
David Seales
Facility & Packaging Manager
Women Entrepreneurship Strategy
FedDev Ontario works to create economic growth opportunities in southern Ontario by helping businesses become more competitive, innovative, and productive.
The government of Canada is advancing women’s economic empowerment with the first-ever Women Entrepreneurship Strategy (WES) to supporting women entrepreneurs with the federal fund to increase women-owned businesses’ access to the financing, talent, networks and expertise they need to start-up, scale up and access new markets.
At Seaford Pharmaceuticals we are grateful to be recipients of the federal fund and to assist us in achieving our goal to being a market leader in key therapeutic areas with high-value healthcare products and helping to improve patient outcomes.
